Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Transplantation
100%
Oregon
100%
Chronic Myeloid Leukemia
100%
Yes-No
100%
Imatinib
25%
Imatinib Mesylate
25%
Targeted Agents
25%
Treatment Options
25%
Hematopoietic Stem Cells
25%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
25%
Stem Cell Deficiency
25%
Treatment-related Mortality
25%
Current Management
25%
Leukemia Patients
25%
Transplant Eligibility
25%
Donor Pretreatment
25%
Donor Availability
25%
Patient numbers
25%
Curative Potential
25%
Treatment-related Morbidity
25%
Optimal Decision Making
25%
Medicine and Dentistry
Chronic Myelogenous Leukemia
100%
Imatinib
50%
Decision Making
25%
Morbidity
25%
Allogeneic Stem Cell Transplantation
25%
Hematopoietic Cell
25%
Diseases
25%
Treatment Option
25%
Nursing and Health Professions
Chronic Myeloid Leukemia
100%
Imatinib
50%
Morbidity
25%
Allogeneic Stem Cell Transplantation
25%
Diseases
25%
Efficacy
25%
Neuroscience
Imatinib
100%
Stem Cell
50%
Hematopoietic Cell
50%
Decision Making
50%